These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

840 related items for PubMed ID: 19238538

  • 1. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
    Arisan ED, Kutuk O, Tezil T, Bodur C, Telci D, Basaga H.
    Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538
    [Abstract] [Full Text] [Related]

  • 2. The small organic compound HA14-1 prevents Bcl-2 interaction with Bax to sensitize malignant glioma cells to induction of cell death.
    Manero F, Gautier F, Gallenne T, Cauquil N, Grée D, Cartron PF, Geneste O, Grée R, Vallette FM, Juin P.
    Cancer Res; 2006 Mar 01; 66(5):2757-64. PubMed ID: 16510597
    [Abstract] [Full Text] [Related]

  • 3. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O, Arce F, Gätjens-Boniche O, Díaz C.
    Biomed Pharmacother; 2007 Jul 01; 61(6):347-55. PubMed ID: 17399942
    [Abstract] [Full Text] [Related]

  • 4. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM, Turchi JJ.
    Cancer Res; 1999 Jul 01; 59(13):3077-83. PubMed ID: 10397248
    [Abstract] [Full Text] [Related]

  • 5. Combined proteasome and Bcl-2 inhibition stimulates apoptosis and inhibits growth in EBV-transformed lymphocytes: a potential therapeutic approach to EBV-associated lymphoproliferative diseases.
    Srimatkandada P, Loomis R, Carbone R, Srimatkandada S, Lacy J.
    Eur J Haematol; 2008 May 01; 80(5):407-18. PubMed ID: 18221384
    [Abstract] [Full Text] [Related]

  • 6. Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells.
    Campàs C, Cosialls AM, Barragán M, Iglesias-Serret D, Santidrián AF, Coll-Mulet L, de Frias M, Domingo A, Pons G, Gil J.
    Exp Hematol; 2006 Dec 01; 34(12):1663-9. PubMed ID: 17157163
    [Abstract] [Full Text] [Related]

  • 7. Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2.
    Chu F, Barkinge J, Hawkins S, Gudi R, Salgia R, Kanteti PV.
    Cancer Res; 2005 Jun 15; 65(12):5301-9. PubMed ID: 15958577
    [Abstract] [Full Text] [Related]

  • 8. Bcl-2 inhibitors sensitize tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by uncoupling of mitochondrial respiration in human leukemic CEM cells.
    Hao JH, Yu M, Liu FT, Newland AC, Jia L.
    Cancer Res; 2004 May 15; 64(10):3607-16. PubMed ID: 15150119
    [Abstract] [Full Text] [Related]

  • 9. Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells.
    Cho HJ, Kim JK, Kim KD, Yoon HK, Cho MY, Park YP, Jeon JH, Lee ES, Byun SS, Lim HM, Song EY, Lim JS, Yoon DY, Lee HG, Choe YK.
    Cancer Lett; 2006 Jun 08; 237(1):56-66. PubMed ID: 16009487
    [Abstract] [Full Text] [Related]

  • 10. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
    Aroui S, Brahim S, De Waard M, Bréard J, Kenani A.
    Cancer Lett; 2009 Nov 18; 285(1):28-38. PubMed ID: 19523755
    [Abstract] [Full Text] [Related]

  • 11. Translocation of Bax to mitochondria induces apoptotic cell death in indole-3-carbinol (I3C) treated breast cancer cells.
    Rahman KM, Aranha O, Glazyrin A, Chinni SR, Sarkar FH.
    Oncogene; 2000 Nov 23; 19(50):5764-71. PubMed ID: 11126363
    [Abstract] [Full Text] [Related]

  • 12. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
    Hasenjäger A, Gillissen B, Müller A, Normand G, Hemmati PG, Schuler M, Dörken B, Daniel PT.
    Oncogene; 2004 Jun 03; 23(26):4523-35. PubMed ID: 15064710
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells.
    Lieber J, Kirchner B, Eicher C, Warmann SW, Seitz G, Fuchs J, Armeanu-Ebinger S.
    Pediatr Blood Cancer; 2010 Dec 01; 55(6):1089-95. PubMed ID: 20680965
    [Abstract] [Full Text] [Related]

  • 14. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
    Ikuta K, Takemura K, Kihara M, Naito S, Lee E, Shimizu E, Yamauchi A.
    Oncol Rep; 2005 Jun 01; 13(6):1229-34. PubMed ID: 15870947
    [Abstract] [Full Text] [Related]

  • 15. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
    Aranha O, Grignon R, Fernandes N, McDonnell TJ, Wood DP, Sarkar FH.
    Int J Oncol; 2003 Apr 01; 22(4):787-94. PubMed ID: 12632069
    [Abstract] [Full Text] [Related]

  • 16. Induction of apoptosis in MCF-7 and MDA-MB-231 breast cancer cells by Oligonol is mediated by Bcl-2 family regulation and MEK/ERK signaling.
    Jo EH, Lee SJ, Ahn NS, Park JS, Hwang JW, Kim SH, Aruoma OI, Lee YS, Kang KS.
    Eur J Cancer Prev; 2007 Aug 01; 16(4):342-7. PubMed ID: 17554207
    [Abstract] [Full Text] [Related]

  • 17. Critical role of Bid and Bax in indirubin-3'-monoxime-induced apoptosis in human cancer cells.
    Shi J, Shen HM.
    Biochem Pharmacol; 2008 May 01; 75(9):1729-42. PubMed ID: 18377873
    [Abstract] [Full Text] [Related]

  • 18. Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor.
    An J, Chervin AS, Nie A, Ducoff HS, Huang Z.
    Oncogene; 2007 Feb 01; 26(5):652-61. PubMed ID: 16909121
    [Abstract] [Full Text] [Related]

  • 19. Epothilone B analogue (BMS-247550)-mediated cytotoxicity through induction of Bax conformational change in human breast cancer cells.
    Yamaguchi H, Paranawithana SR, Lee MW, Huang Z, Bhalla KN, Wang HG.
    Cancer Res; 2002 Jan 15; 62(2):466-71. PubMed ID: 11809697
    [Abstract] [Full Text] [Related]

  • 20. Curcumin sensitizes lung cancer cells to cisplatin-induced apoptosis through superoxide anion-mediated Bcl-2 degradation.
    Chanvorachote P, Pongrakhananon V, Wannachaiyasit S, Luanpitpong S, Rojanasakul Y, Nimmannit U.
    Cancer Invest; 2009 Jul 15; 27(6):624-35. PubMed ID: 19283527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.